The loss of antibiotic activity of ciprofloxacin by photodegradation

Journal of Antimicrobial Chemotherapy

Volumn 26, Issue 6, 1990, Pages 783-789

  Phillips, G ^a   Johnson, B E ^a   Ferguson, J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG ACTIVITY; ESCHERICHIA COLI; NONHUMAN; PHOTODEGRADATION; PRIORITY JOURNAL; RADIATION; ULTRAVIOLET RADIATION;

CIPROFLOXACIN; ESCHERICHIA COLI; LIGHT; MICROBIAL SENSITIVITY TESTS; PHOTOCHEMISTRY; SUNLIGHT; SUPPORT, NON-U.S. GOV'T; ULTRAVIOLET RAYS;

EID: 0025695544     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/26.6.783     Document Type: Article

References (29)

1. Arderi, G., Griffith, E., Gruenwaldt, G., Heyd, A., O’Brien, B., Becker, N. et al. (1987). Ciprofloxacin: an update on clinical experience. American Journal of Medicine 82, Suppl. 4 A, 381-6.
2. Bakri, A., Bdjersbergen van Henegouwen, G. & Chanal, J. L. (1985). Involvement of the N4-oxide group in the phototoxicity of chlordiazepoxide in the rat. Photodermatology 2, 205-12.
3. Bennett, J. V., Brodie, J. L., Benner, E. J. & Kirby, W. M. M. (1966). Simplified, accurate method for antibiotic assay of clinical specimens. Applied Microbiology 14, 170-7.
4. Bhadresa, B. & Sugden, J. K. (1981). Light transmittance through amber glass medicine bottles. Pharmaceutica Acta Helvetiae 56, 122-4.
5. Birkett, D. A., Garretts, M. & Stevenson, C. J. (1969). Phototoxic bullous eruptions due to nalidixic add. British Journal of Dermatology 81, 342-4.
6. Boisvert, A. & Barbeau, G. (1981). Nalidixic add-induced photodermatitis after minimal sun exposure. Drug Intelligence and Clinical Pharmacy 15, 126-7.
7. Dimbleby, V. (1953). Glass for pharmaceutical purposes. Journal of Pharmacy and Pharmacology 5, 969-89.
8. Ferguson, J. & Johnson, B. E. (1990). Ciprofloxadn-induced photosensitivity: in vitro and in vivo studies. British Journal of Dermatology 123, 9-20.
9. Ferguson, J., Phillips, G., McEwan, J., Moreland, T. & Johnson, B. E. (1988). Loss of antibiotic activity caused by photodegradation: in vivo studies. British Journal of Dermatology 119, 550-1.
10. Fernández, E. & Cárdenas, A. M. (1990). The mechanism of photohaemolysis by photoproducts of nalidixic add. Journal of Photochemistry and Photobiology, B: Biology 4, 329-33.
11. Garrod, L. P., Lambert, H. P. & O’Grady, F. (1981). Antibiotic and Chemotherapy, 5th edn. Churchill Livingstone, Edinburgh.
12. Gerber, P. (1988). Mass product-liability litigation. Medical Journal of Australia 148, 485-8.
13. Gibbs, N. K. & Young, A. R. (1983). An evaluatibn of nalidixic add film as a UV-A radiation dosimeter. Photochemistry and Photobiology 37, 345-8.
14. Harber, L. C. & Bickers, D. R. (1989). Photosensitivity Diseases: Principles of Diagnosis and Treatment, 2nd edn. B. C. Decker Inc., Philadelphia, PA.
15. Hooper, D. C. & Wolfson, J. S. (1989). Adverse effects of quinolone antimicrobial agents. In Quinolone Antimicrobial Agents (Wolfson, J. S. & Hooper, D.C., Eds), pp. 249-71. American Sodety for Microbiology, Washington, DC.
16. Jensen, T., Pedersen, S. S., Nielsen, C. H., Hoiby, N. & Koch, C. (1987). The efficacy and safety of dprofloxadn and ofloxadn in chronic Pseudomonas aeruginosa infection in cystic fibrosis. Journal of Antimicrobial Chemotherapy 20, 585-94.
17. Johnson, B. E. (1973). Chlorpromazine phototoxidty: a non-classical mode of action. British Journal of Dermatology 89, Suppl. 9, 16-7.
18. Johnson, B. E. (1984). Light sensitivity assodated with drugs and chemicals. In The Physiology and Pathophysiology of the Skin, Vol. 8 (Jarrett, A., Ed.), pp. 2541-606. Academic Press, New York.
19. Johnson, F. S., Mo, T. & Green, A. E. S. (1976). Average latitudinal variation in ultraviolet radiation at the earth’s surface. Photochemistry and Photobiology 23, 179-88.
20. Kochevar, I. E. (1980). Possible mechanisms of toxidty due to photochemical products of protriptyline. Toxicology and Applied Pharmacology 54, 258-64.
21. Ljunggren, B. & Bjellerup, M. (1986). Systemic drug photosensitivity. Photodermatology 3, 26-35.
22. Mackenzie, L. A. & Frain-Bell, W. (1973). The construction and development of a grating monochromator and its application to the study of the reaction of the skin to light. British Journal of Dermatology 89, 251-64.
23. Moore, D. E., Hemmens, V. J. & Yip, H. (1984). Photosensitization by drugs: nalidixic and oxolinic adds. Photochemistry and Photobiology 39, 57-61.
24. Oppenlander, T. (1988). A comprehensive photochemical and photophysical assay exploring the photoreactivity of drugs. Chimia 42, 331-42.
25. Parrish, J. A., Anderson, R. R., Urbach, F. & Pitts, D. (1978). UV-A. Biological Effects of Ultraviolet Radiation with Emphasis on Human Responses to Longwave Ultraviolet. Plenum Press, New York.
26. Pathak, M. A. (1982). Sunscreens: topical and systemic approaches for protection of human skin against harmful effects of solar radiation. Journal of the American Academy of Dermatology7, 285-312.
27. Schoonderwoerd, S. A., Beijersbergen van Hencgouwen, G. M. J. & van Belkum, S. (1989). In vivo photodegradation of chlorpromazine. Photochemistry and Photobiology 50, 659-64.
28. Tate, T. J., Diffey, B. L. & Davis, A. (1980). An ultraviolet radiation dosimeter based on the photosensitising drug, nalidixic add. Photochemistry and Photobiology 31, 27-30.
29. Zelickson, A. S. (1964). Phototoxic reaction with nalidixic add. Journal of the American Medical Association 190, 556-7.